Stocktoria
Vericel Corp VCEL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1997-02-04
Vericel Corp insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Flynn Sean C. | Chief Legal Officer | 2026-06-18 | Sell | 15,000 | $40.21 |
| Flynn Sean C. | Chief Legal Officer | 2026-06-18 | Option exercise | 15,000 | $16.25 |
| Halpin Michael | Chief Operating Officer | 2026-06-18 | Option exercise | 10,000 | $16.66 |
| Halpin Michael | Chief Operating Officer | 2026-06-18 | Sell | 10,000 | $40.24 |
| Hopper Jonathan Mark | Chief Medical Officer | 2026-06-02 | Option exercise | 4,375 | $16.66 |
| Hopper Jonathan Mark | Chief Medical Officer | 2026-06-02 | Sell | 4,375 | $35.00 |
| MCLAUGHLIN KEVIN F | director | 2026-05-13 | Sell | 3,500 | $32.83 |
| MCLAUGHLIN KEVIN F | director | 2026-05-13 | Option exercise | 3,500 | $2.63 |
Source: SEC EDGAR filings · CIK 0000887359 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.